Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniele Colazzo
Observed name:
D. Colazzo
Institutions:
Azienda Ospedaliero-Universitaria Careggi,
University of Florence
Observed institutions:
Azienda Ospedaliero-Universitaria Careggi,
University of Florence,
University of Palermo
ORCID:
0009-0001-9645-8563
Observed ORCID:
0009-0001-9645-8563
OpenAlex ID:
A5070875271
Application of Cloning-Free Genome Engineering to Escherichia coli
2023
·
Lucia Romeo
, Antonia Esposito
, et al.
·
Microorganisms
·
4
PDF
Molecular predictors of survival in patients with myeloproliferative neoplasm-blast Phase (MPN-BP) treated with venetoclax and decitabine
2025
·
Paola Guglielmelli
, Francesca Crupi
, et al.
·
Blood
·
3
PDF
A novel approach for highly sensitive and rapid identification of HMGA2 submicroscopic deletions in myeloproliferative neoplasms
2025
·
Niccolò Bartalucci
, Danilo Tarantino
, et al.
·
Leukemia
·
3
PDF
Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia
2026
·
Niccolò Bartalucci
, Francesco Mannelli
, et al.
·
Blood Cancer Journal
·
1
PDF
A Novel, Ruxolitinib‐Sensitive, CCDC6 :: JAK2 Fusion Gene in a Patient With Atypical, JAK2 Unmutated, Polycythemia Vera‐Like, Myeloproliferative Neoplasm
2025
·
Niccolò Bartalucci
, Danilo Tarantino
, et al.
·
American Journal of Hematology
·
1
PDF
The selective PI3Kδ inhibitor roginolisib synergizes with ruxolitinib against progenitor cells from naïve and JAK inhibitor-refractory/resistant patients with myelofibrosis
2025
·
Manjola Balliu
, Valentina Boldrini
, et al.
·
Blood
·
1
PDF
POSTER: MPN-545: The Selective PI3KδInhibitor Roginolisib Synergizes With JAK Inhibitors in Progenitor Cells From Naïve and JAK Inhibitor–Refractory/Resistant Patients With Myelofibrosis
2026
·
Manjola Balliu
, Valentina Boldrini
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MPN-545: The Selective PI3KδInhibitor Roginolisib Synergizes With JAK Inhibitors in Progenitor Cells From Naïve and JAK Inhibitor–Refractory/Resistant Patients With Myelofibrosis
2026
·
Manjola Balliu
, Valentina Boldrini
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Correction: A novel approach for highly sensitive and rapid identification of HMGA2 submicroscopic deletions in myeloproliferative neoplasms
2025
·
Niccolò Bartalucci
, Danilo Tarantino
, et al.
·
Leukemia
PDF
Identification of Genomic Structural Variants (SVs) with Adverse Prognostic Significance in Normal-Karyotype (nk) Acute Myeloid Leukemia (AML) Patients
2024
·
Niccolò Bartalucci
, Francesco Mannelli
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
12
Citation count:
13
H-index:
3
I10-index:
Year
Topic
Type